Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alvimopan for opioid-induced bowel dysfunction in cancer pain patients (Phase IIb extension)
2004-001814-14Phase 2Terminated
- Sponsor
- GSK
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in opioid-induced bowel dysfunction (OIBD) comparing Alvimopan multiple dosage regimens with Placebo (2 arms). Primary endpoint: Incidence of reported adverse events. Started Oct 2005; status: terminated.
02
Drugs
alvimopan
03
Conditions
opioid-induced bowel dysfunction (OIBD)
Beyond the preview
Go deeper on 2004-001814-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001814-14.